You are here: Industry Insights > Merck

News List

Merck and Skyhawk Therapeutics sign collaboration agreement pharmaceutical-technology
July 10, 2019
Merck has signed a strategic collaboration agreement with Skyhawk Therapeutics to use its SkySTAR technology to develop drug candidates for patients with neurodegenerative diseases and cancer.
Merck and Utah University find potential diabetes drug target pharmaceutical-technology
July 09, 2019
Merck Research Laboratories and the University of Utah Health have shown that deactivation of the dihydroceramide desaturase 1 (DES1) enzyme could offer a potential drug target for metabolic diabetes.
TILT Biotherapeutics to Collaborate with Merck KGaA and Pfizer contractpharma
July 04, 2019
To investigate the combination of oncolytic virus, TILT-123, and anti-PDL1 antibody, avelumab.
Merck, Pfizer keep high-flying vaccine sales intact with key CDC backing fiercepharma
July 04, 2019
Looking ahead, the two companies could end up in a new head-to-head contest with their next-generation pneumococcal vaccines with billions of dollars at stake. Pfizer is developing its 20-valent follow-up to Prevnar 13, while Merck has a 15-valent vaccine
Merck builds first Mobile Lab to conduct protein research campaigns biospectrumasia
June 28, 2019
Merck's “Mobile Lab” will open 20 campuses across China, sharing knowledge on protein research through live demonstrations combined with digital technology
IBM, KPMG, Merck and Walmart to evaluate the use of blockchain in pharma biospectrumasia
June 16, 2019
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
Merck’s Keytruda secures expanded indications in US pharmaceutical-technology
June 14, 2019
The US Food and Drug Administration (FDA) has approved two indications for Merck’s Keytruda, expanding its application to the oncology market.
Merck buys Tilos Therapeutics in a $773M deal biospectrumasia
June 13, 2019
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ
Merck to acquire Tilos Therapeutics for $773m pharmaceutical-technology
June 13, 2019
Merck has signed an agreement to buy biopharmaceutical company Tilos Therapeutics for a total consideration of up to $773m.
Merck, Rigaku to form molecular structure analysis technology collab pharmatimes
June 11, 2019
Rigaku and Merck have announced plans to form a partnership to develop novel molecular structure analysis technology.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page